1. Home
  2. MBOT vs NXPL Comparison

MBOT vs NXPL Comparison

Compare MBOT & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Microbot Medical Inc.

MBOT

Microbot Medical Inc.

HOLD

Current Price

$2.23

Market Cap

126.3M

Sector

Health Care

ML Signal

HOLD

Logo NextPlat Corp

NXPL

NextPlat Corp

HOLD

Current Price

$0.62

Market Cap

25.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBOT
NXPL
Founded
2010
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
126.3M
25.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MBOT
NXPL
Price
$2.23
$0.62
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$8.75
N/A
AVG Volume (30 Days)
3.0M
167.9K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$57,151,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2,166.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.93
$0.43
52 Week High
$4.67
$2.30

Technical Indicators

Market Signals
Indicator
MBOT
NXPL
Relative Strength Index (RSI) 46.82 43.43
Support Level $2.31 $0.62
Resistance Level $2.55 $0.70
Average True Range (ATR) 0.17 0.06
MACD 0.03 0.01
Stochastic Oscillator 52.11 27.46

Price Performance

Historical Comparison
MBOT
NXPL

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

Share on Social Networks: